Proyectos I+D+I
Project H2020-MSCA-COFUND-2020 PROOOPI 801
Field-controlled magnetoelectric core-shell-shell nanoparticles as remote magnetic intracellular hyperthermia and on-demand drug release for targeted therapy of breast cancer cells (HIReCell)
Funder: UNIÓN EUROPEA
Call: (UNIÓN EUROPEA)
edit_calendar
Duration: from 01 March 2024 to 31 August 2026
(30 months)
Current
€197,800.00
Of European scope. It has been granted under a regime of Competitive.
Researchers
David
Díez Martín
Leader
Valentín
Nica
Leader